Beacon Transcript

Information which Matters to You

Monday, March 8, 2021
Log in
  • National News
  • National News
  • Business
  • Business
  • Technology
  • Technology
  • Health
  • Health
  • Science
  • Science
  • About Us
    • Contact Us
    • Authors & Contributors
    • Privacy Policy GDPR
  • About Us
    • Contact Us
    • Authors & Contributors
    • Privacy Policy GDPR

Recent Articles

Ancient Babylonian Clay Tablet Holds the First Trigonometric Table

Ancient Babylonian Clay Tablet Holds the First Trigonometric Table

August 26, 2017 By Clayton Meason

The CDC Draws Attention To The Spike In Cyclosporiasis Cases

The CDC Draws Attention To The Spike In Cyclosporiasis Cases

August 11, 2017 By Troy G. Bennett

Travis Kalanick Resigns from His Position as Uber’s CEO

Travis Kalanick Resigns from His Position as Uber’s CEO

June 22, 2017 By Troy G. Bennett

Amazon Refunds Parents Whose Children Made Purchases Without Permission

Amazon Refunds Parents Whose Children Made Purchases Without Permission

June 2, 2017 By Clayton Meason

McDonald’s Has Been Quietly Altering Its Vanilla Ice Cream Recipe

McDonald’s Has Been Quietly Altering Its Vanilla Ice Cream Recipe

May 21, 2017 By Jennifer Licata

Washington Post Will Be Expanding Its Newsroom

Washington Post Will Be Expanding Its Newsroom

December 28, 2016 By Troy G. Bennett

Clot Drug Was Employed to Treat Hemorrhagic Strokes

February 19, 2016 By Angelina Stapp

Email, RSS Follow
"Clot Drug Was Employed to Treat Hemorrhagic Strokes"

The drug heavily used during the 90s to treat cardiac blood clots can now be employed in order to reduce the death risk in patients who have suffered a hemorrhagic stroke.

BEACON TRANSCRIPT – A new clinical trial shows promising results in treating hemorrhagic strokes using a clot-busting drug. The clot drug was employed to treat hemorrhagic strokes, thus reducing the risk of death by nearly 10 percent. Phase III of the study proved that patients treated with the clot-busting drug are more likely to live on their own than those treated with a saline solution.

A group of medical researcher, engaged in an ample and lengthy clinical trial, has just announced the results of the third phase of the international clinical trial. The project was conducted at Johns Hopkins Hospital. According to the summary of the text, a drug mainly used to treat cardiac clots, can be employed to treat patients who experienced brain strokes, a condition known to cause swelling and brain bleeding.

The study and its results were presented on the 18th of February during the Internal Stroke Conference, which took place in Los Angeles. According to their conclusion, a patient has high chances of returning home after 180 days, if his or hers condition is treated using either the clot-busting drug or a saline solution.

Furthermore, the medical examiners have discovered that flushing the excess blood from the brain using either of the two solutions can greatly increase the patient’s chances of survival. According to their initial projections, approximately 50 percent of patients treating using the methods listed above will survive and return home.

Daniel Hanley Jr., the director of the Brain Injury Outcome Program declared in a press interview that the clot-busting drug also known as tPA (tissue plasminogen activator) can save one in ten live if applied after the patient is hemodynamically stable, meaning that the doctors can use this drug only if they were successful in stopping the bleeding occurring in the brain.

The clot drug employed to treat hemorrhagic strokes showed promising results in the case of hemodynamically stable patients.

The clinical trial involving the use of cardiac clot busters in treating hemorrhagic brain strokes began in 2000. Hanley and his team of scientists constructed their premises on the brick foundation laid out in the 90s by the former director of Johns Hopkins Department of Medicine, by the name of Myron Weisfeldt. Doctor Weisfeldt was one the first physicians to study the effects of the wonder-drug called tPA.

In order to see if the drug is indeed capable of increasing the odds of surviving a hemorrhagic brain stroke, the team of medical researchers enlisted the help of approximately 500 patients from 73 research center. All the patients were of white, Latino and African-American descent and each of them suffered a hemorrhagic stroke sometime before the study.

Hanley and his team were certain that tPA has the potential of increasing the patient’s chances of survival by dissolving the blood clots found in the brain and clearing out the excess blood found in the ventricles.

The actual testing procedure of the drug meant that Hanley must have chosen a study group that fulfilled certain requirements. The first condition implied that all patients enrolled in the study were hemodynamically stable. Second, the clot must have been stable, meaning that if it grew or changed shape, the patients was no longer eligible to participate in the clinical study.

After choosing their study group, the team focused on treated a specific aspect of the event. According to Hanley, his team targeted those individual showing small inner brain bleedings, followed by a larger intraventricular bleeding. All the blood clots which were meant to be treated using either of the two solutions were roughly the size of a ping-pong ball.

After selection, each patient randomly received either saline or the tPA drug. But before the solutions could be employed, the doctors gave the group blood pressure stabilizers. Moreover, the patients also received a brain catheter, a medical device used to transport drugs to a specific portion of the brain. The catheter was either used to pump out the excess blood using either one milligram of tPA or a saline-based solution.

The standardized treatment included 12 doses of tPA or saline, which were administered at an 8-hour interval. They also received a rigorous follow-up exam, accompanied by a CT scan, at the end of the 30th and 180th day.

According to their results, approximately 249 of patients who received saline had a 29% death rate, while those treated with tPA experienced a 19 percent death rate. Moreover, the results also proved that patients treated with the clot-busting drug had 49 percent fewer chances of experiencing side effects or to become infected with a deadly bacteria.

Photo credits:www.wikipedia.org

Email, RSS Follow

Filed Under: Health Tagged With: blood clots, brain bleeding, brain stroke, drug used to cure blood clots, new drug, new study on hemorrhagic strokes

Recent Posts

  • Security Guard List As Suspect in 1974 Stanford University Chapel Slaying Kills Himself June 29, 2018
  • Texas Teens Arrested After Decomposing Body of Elderly Woman Found in Garage June 28, 2018
  • Montana Woman in Custody After Forcing Ex to Have Sex with Her June 27, 2018
  • Newly Released Audio Transcript Proves Monalisa Perez Objected to Deadly YouTube Prank June 26, 2018
  • Virginia Woman Shoots New Zealand Man Who Smashed Glass Door with Brick   June 26, 2018
  • Arizona Woman Lied About Kidnapping to Cover Boyfriend’s Slaying June 25, 2018
  • Brooklyn Man Arrested in Niagara Falls Allegedly Chopped off Pregnant Wife’s Arms with Steak Knife June 25, 2018

Related Articles

  • green laser

    Boy from Greece Burns Hole Through Retina after Staring into Green Laser

    Jun 21, 2018
  • machine brain

    Google’s Latest AI Algorithm Can Predict the Likelihood of Death

    Jun 19, 2018
  • Kat von D

    Beauty Blogger Tears Down Kat von D’s Anti-Vaxx Post with Pictures of Son with Measles

    Jun 15, 2018
  • white cell

    Terminally Ill Patient Now Cancer Free Thanks to Experimental Treatment  

    Jun 7, 2018
  • eggplant

    Chinese Man Inserts Foot-Long Eggplant in Anus to Get Rid of Constipation

    Jun 5, 2018
  • pregnancy

    Scotland OB-GYN Specialist Found Guilty of Medical Misconduct in Birth of Headless Infant

    Jun 5, 2018
  • gym day

    Texas Teen Diagnosed with Potentially Deadly Muscle Disease after Over Exercising at the Gym

    Jun 4, 2018
  • a bandaged hand extended towards the left side of the screen

    New, Handheld 3D Skin Printer to Be Used to Heal Deep Wounds? (Study)

    May 9, 2018
  • Car Crash Leads to Brain Tumor

    California Student Gets Diagnosed with Thumb-Sized Brain Tumor after Car Crash

    Mar 21, 2018
  • Air pocket in Man's Brain

    Irish Man Found with Large Air Pocket on Right Side of the Brain

    Mar 14, 2018

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Science
  • Stocks
  • Technology
  • US
  • World

Copyright © 2021 beacontranscript.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.